The origin and function of soluble CD14 in experimental bacterial meningitis

Journal of Immunology

Volumn 162, Issue 8, 1999, Pages 4762-4772

  Cauwels, Anje ^a,b   Frei, Karl ^c   Sansano, Sebastiano ^b   Fearns, Colleen ^d   Ulevitch, Richard ^d   Zimmerli, Werner ^b   Landmann, Regine ^b  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; CYTOKINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 6; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; ASTROCYTE; BACTERIAL MENINGITIS; BLOOD LEVEL; BRAIN; CEREBROSPINAL FLUID LEVEL; CHILD; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HUMAN; LEUKOCYTE; LISTERIA MONOCYTOGENES; MAJOR CLINICAL STUDY; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; VIRUS MENINGITIS;

ANIMALS; ANTIGENS, CD14; ASTROCYTES; BRAIN; CHILD; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; LEUKOCYTES; LISTERIA INFECTIONS; MENINGITIS, BACTERIAL; MICE; MICE, INBRED C57BL; MICROGLIA; PNEUMOCOCCAL INFECTIONS; RECOMBINANT PROTEINS; RNA, MESSENGER; SOLUBILITY;

EID: 0033561758     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Bryan, J. P., H. R. de Silva, A. Tavares, H. Rocha, and W. M. Scheld. 1990. Etiology and mortality of bacterial meningitis in northeastern Brazil. Rev. Infect. Dis. 12:128.
2. Wenger, J. D., A. W. Hightower, R. R. Facklam, S. Gaventa, and C. V. Broome. 1990. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J. Infect. Dis. 162:1316.
3. Bohr, V., O. B. Paulson, and N. Rasmussen. 1984. Pneumococcal meningitis: late neurologic sequelae and features of prognostic impact. Arch. Neurol. 41:1045.
4. Dodge, P. R. 1986. Sequelae of bacterial meningitis. Pediatr. Infect. Dis. J. 5:618.
5. Durand, M. L., S. B. Calderwood, D. J. Weber, S. I. Miller, F. S. Southwick, V. S. Caviness, Jr., and M. N. Swartz. 1993. Acute bacterial meningitis in adults: a review of 493 episodes. N. Engl. J. Med. 328:21.
6. Lorber, B. 1997. Listeriosis. Clin. Infect. Dis. 24:1.
7. Pfister, H. W., and W. M. Scheld. 1997. Brain injury in bacterial meningitis: therapeutic implications. Curr. Opin. Neurol. 10:254.
8. Ramilo, O., X. Saez-Llorens, J. Mertsola, H. Jafari, K. D. Olsen, E. J. Hansen, M. Yoshinaga, S. Ohkawara, H. Nariuchi, and G. H. McCracken, Jr. 1990. Tumor necrosis factor α/cachectin and interleukin 1 β initiate meningeal inflammation. J. Exp. Med. 172:497.
9. Saukkonen, K., S. Sande, C. Cioffe, S. Wolpe, B. Sherry, A. Cerami, and E. Tuomanen. 1990. The role of cytokines in the generation of inflammation and tissue damage in experimental Gram-positive meningitis. J. Exp. Med. 171:439.
10. Seebach, J., D. Bartholdi, K. Frei, K. S. Spanaus, E. Ferrero, U. Widmer, S. Isenmann, R. M. Strieter, M. Schwab, H. Pfister et al. 1995. Experimental Listeria meningoencephalitis: macrophage inflammatory protein-1 α and -2 are produced intrathecally and mediate chemotactic activity in cerebrospinal fluid of infected mice. J. Immunol. 155:4367.
11. Spanaus, K. S., D. Nadal, H. W. Pfister, J. Seebach, U. Widmer, K. Frei, S. Gloor, and A. Fontana. 1997. C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro. J. Immunol. 158:1956.
12. Ernst, J. D., K. T. Hartiala, I. M. Goldstein, and M. A. Sande. 1984. Complement (C5)-derived chemotactic activity accounts for accumulation of polymorphonuclear leukocytes in cerebrospinal fluid of rabbits with pneumococcal meningitis. Infect. Immun. 46:81.
13. 2 in experimental meningitis. J. Infect. Dis. 160:715.
14. Stahel, P. F., K. Frei, H. P. Eugster, A. Fontana, K. M. Hummel, R. A. Wetsel, R. S. Ames, and S. R. Barnum. 1997. TNF-α-mediated expression of the receptor for anaphylatoxin C5a on neurons in experimental Listeria meningoencephalitis. J. Immunol. 159:861.
15. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431.
16. Zhang, Y., M. Doerfler, T. C. Lee, B. Guillemin, and W. N. Rom. 1993. Mechanisms of stimulation of interleukin-1β and tumor necrosis factor-α by Mycobacterium tuberculosis components. J. Clin. Invest. 91:2076.
17. Pugin, J., I. D. Heumann, A. Tomasz, V. V. Kravchenko, Y. Akamatsu, M. Nishijima, M. P. Glauser, P. S. Tobias, and R. J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity 1:509.
18. De Waal Malefyt, R., C. G. Figdor, R. Huijbens, S. Mohan-Peterson, B. Bennett, J. Culpepper, W. Dang, G. Zurawski, and J. E. de Vries. 1993. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-γ or IL-10. J. Immunol. 151:6370.
19. Landmann, R., H. P. Knopf, S. Link, S. Sansano, R. Schumann, and W. Zimmerli. 1996. Human monocyte CD14 is up-regulated by lipopolysaccharide. Infect. Immun. 64:1762.
20. Frey, E. A., D. S. Miller, T. G. Jahr, A. Sundan, V. Bazil, T. Espevik, B. B. Finlay, and S. D. Wright. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176:1665.
21. Pugin, J., C. C. Schurer-Maly, D. Leturcq, A. Moriarty, R. J. Ulevitch, and P. S. Tobias. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 90:2744.
22. Haziol, A., G. W. Rong, J. Silver, and S. M. Goyert. 1993. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J. Immunol. 151:1500.
23. Loppnow, H., F. Stelter, U. Schonbeck, C. Schluter, M. Ernst, C. Schutt, and H. D. Flad. 1995. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD 14. Infect. Immun. 63:1020.
24. Haziot, A., G. W. Rong, V. Bazil, J. Silver, and S. M. Goyert. 1994. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-α production by cells in whole blood. J. Immunol. 152:5868.
25. Haziot, A., G. W. Rong, X. Y. Lin, J. Silver, and S. M. Goyert. 1995. Recombinant soluble CD14 prevents mortality in mice treated with endotoxin (lipopolysaccharide). J. Immunol. 154:6529.
26. Landmann, R., W. Zimmerli, S. Sansano, S. Link, A. Hahn, M. P. Glauser, and T. Calandra. 1995. Increased circulating soluble CD14 is associated with high mortality in Gram-negative septic shock. J. Infect. Dis. 171:639.
27. Wenisch, C., H. Wenisch, B. Parschalk, S. Vanijanonta, H. Burgmann, M. Exner, K. Zedwitz-Liebenstein, F. Thalhammer, A. Georgopoulos, W. Graninger, and S. Looareesuwan. 1996. Elevated levels of soluble CD14 in serum of patients with acute Plasmodium falciparum malaria. Clin. Exp. Immunol. 105:74.
28. Nockher, W. A., L. Bergmann, and J. E. Scherberich. 1994. Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin. Exp. Immunol. 98:369.
29. Nockher, W. A., R. Wigand, W. Schoeppe, and J. E. Scherberich. 1994. Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus. Clin. Exp. Immunol. 96:15.
30. Lorenz, H. M., C. Antoni, T. Valerius, R. Repp, M. Grunke, N. Schwerdtner, H. Nusslein, J. Woody, J. R. Kalden, and B. Manger. 1996. In vivo blockade of TNF-α by intravenous infusion of a chimeric monoclonal TNF-α antibody in patients with rheumatoid arthritis: short term cellular and molecular effects. J. Immunol. 156:1646.
31. Kruger, C., C. Schutt, U. Obertacke, T. Joka, F. E. Muller, J. Knoller, M. Koller, W. Konig, and W. Schonfeld. 1991. Serum CD14 levels in polytraumatized and severely burned patients. Clin. Exp. Immunol. 85:297.
32. Gebhard, F., M. Rosch, M. Helm, W. Strecker, K. Buttenschon, L. Kinzl, K. H. Bock, and U. B. Bruckner. 1997. Is the activity of soluble CD14 enhanced following major trauma? Arch. Surg. 132:1116.
33. Nadal, D., D. Leppert, K. Frei, P. Gallo, H. Lamche, and A. Fontana. 1989. Tumor necrosis factor-α in infectious meningitis Arch. Dis. Child. 64:1274.
34. Frei, K., D. Nadal, H. W. Pfister, and A. Fontana. 1993. Listeria meningitis: identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin 10. J. Exp. Med. 178:1255.
35. Carp, R. I., A. L. Davidson, and P. A. Merz. 1971. A method for obtaining cerebrospinal fluid from mice. Res. Vet. Sci. 12:499.
36. Heid, C. A., J. Stevens, K. J. Livak, and P. M. Williams. 1996. Real time quantitative PCR. Genome Res. 6:986.
37. Gibson, U. E., C. A. Heid, and P. M. Williams. 1996. A novel method for real time quantitative RT-PCR. Genome Res. 6:995.
38. Fearns, C., V. V. Kravchenko, R. J. Ulevitch, and D. J. Loskutoff. 1995. Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide. J. Exp. Med. 181:857.
39. Fearns, C., and D. J. Loskutoff. 1997. Role of tumor necrosis factor α in induction of murine CD14 gene expression by lipopolysaccharide. Infect. Immun. 65:4822.
40. Frei, K., S. Bodmer, C. Schwerdel, and A. Fontana. 1986. Astrocyte-derived interleukin 3 as a growth factor for microglia cells and peritoneal macrophages. J. Immunol. 137:3521.
41. Bufler, P., G. Stiegler, M. Schuchmann, S. Hess, C. Kruger, F. Stelter, C. Eckerskorn, C. Schutt, and H. Engelmann. 1995. Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants. Eur. J. Immunol. 25:604.
42. Kusunoki, T., E. Hailman, T. S. Juan, H. S. Lichenstein, and S. D. Wright. 1995. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. J. Exp. Med 182:1673.
43. Schumann, R. R., D. Pfeil, D. Freyer, W. Buerger, N. Lamping, C. J. Kirschning, U. B. Goebel, and J. R. Weber. 1998. Lipopolysaccharide and pneumococcal cell wall components activate the mitogen activated protein kinases (MAPK) erk-1, erk-2. and p38 in astrocytes. Glia 22:295.
44. + T-cells. Glia 22:348.
45. Peudenier, S., C. Hery, L. Montagnier, and M. Tardieu. 1991. Human microglial cells: characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection. Ann. Neurol. 29:152.
46. Ulvestad, E., K. Williams, R. Bjerkvig, K. Tiekotter, J. Antel, and R. Matre. 1994. Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells. J. Leukocyte Biol. 56:732.
47. Dick, A. D., M. Pell, B. J. Brew, E. Foulcher, and J. D. Sedgwick. 1997. Direct ex vivo flow cytometric analysis of human microglial cell CD4 expression: examination of central nervous system biopsy specimens from HIV-seropositive patients and patients with other neurological disease. AIDS 11:1699.
48. Peterson, P. K., G. Gekker, S. Hu, W. S. Sheng, W. R. Anderson, R. J. Ulevitch, P. S. Tobias, K. V. Gustafson, T. W. Molitor, and C. C. Chao. 1995. CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect. Immun. 63:1598.
49. Lipovsky, M. M., G. Gekker, W. R. Anderson, T. W. Molitor, P. K. Peterson, and A. I. Hoepelman. 1997. Phagocytosis of nonopsonized Cryptococcus neoformans by swine microglia involves CD14 receptors. Clin. Immunol. Immunopathol. 84: 208.
50. Becher, B., and J. P. Antel. 1996. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia 18:1.
51. Waage, A., A. Halstensen, and T. Espevik. 1987, Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1:355.
52. Waage, A., P. Brandtzaeg, A. Halstensen, P. Kierulf, and T. Espevik. 1989. The complex pattern of cytokines in serum from patients with meningococcal septic shock: association between interleukin 6, interleukin 1, and fatal outcome. J. Exp. Med. 169:333.
53. Waage, A., A. Halstensen, R. Shalaby, P. Brandtzaeg, P. Kierulf, and T. Espevik. 1989. Local production of tumor necrosis factor α, interleukin 1, and interleukin 6 in meningococcal meningitis: relation to the inflammatory response. J. Exp. Med. 170:1859.
54. Arditi, M., K. R. Manogue, M. Caplan, and R. Yogev. 1990. Cerebrospinal fluid cachectin/tumor necrosis factor-α and platelet-activating factor concentrations and severity of bacterial meningitis in children. J. Infect. Dis. 162:139.
55. Borden, E. C., and P. Chin. 1994. Interleukin-6: a cytokine with potential diagnostic and therapeutic roles. J. Lab. Clin. Med. 123:824.
56. Kanoh, Y., and H. Ohtani. 1997. Levels of interleukin-6, CRP and α2 macroglobulin in cerebrospinal fluid (CSF) and serum as indicator of blood-CSF barrier damage. Biochem. Mol. Biol. Int. 43:269.
57. Haziot, A., E. Ferrero, F. Kontgen, N. Hijiya, S. Yamamoto, J. Silver, C. L. Stewart, and S. M. Goyert. 1996. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 4:407.
58. Grunwald, U., X. Fan, R. S. Jack, G. Workalemahu, A. Kallies, F. Stelter, and C. Schutt. 1996. Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism. J. Immunol. 157:4119.
59. Schiff, D. E., L. Kline, K. Soldau, J. D. Lee, J. Pugin, P. S. Tobias, and R. J. Ulevitch. 1997. Phagocytosis of Gram-negative bacteria by a unique CD14-dependent mechanism. J. Leukocyte Biol. 62:786.
60. Onozuka, K., T. Kirikae, F. Kirikae, Y. Suda, S. Kusumoto, S. Yamamoto, T. Shimamura, and M. Nakano. 1997. Participation of CD14 in the phagocytosis of smooth-type Salmonella typhimurium by the macrophage-like cell line, J774.1, Microbiol. Immunol. 41:765.
61. Devitt, A., O. D. Moffatt, C. Raykundalia, J. D. Capra, D. L. Simmons, and C. D. Gregory. 1998. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392:505.
62. Jack, R. S., U. Granwald, F. Stelter, G. Workalemahu, and C. Schutt. 1995. Both membrane-bound and soluble forms of CD14 bind to Gram-negative bacteria. Eur. J. Immunol. 25:1436.
63. Dziarski, R., R. I. Tapping, and P. S. Tobias. 1998. Binding of bacterial peptidoglycan to CD14. J. Biol. Chem. 273:8680.
64. Tofte, R. W., P. K. Peterson, Y. Kim, and P. G. Quie. 1979. Opsonic activity of normal human cerebrospinal fluid for selected bacterial species. Infect. Immun. 26:1093.
65. Simberkoff, M. S., N. H. Moldover, and J. Rahal, Jr. 1980. Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids: a regional host defense deficiency. J. Lab. Clin. Med. 95:362.
66. Porat, R., B. D. Clark, S. M. Wolff, and C. A. Dinarello. 1991. Enhancement of growth of virulent strains of Escherichia coli by interleukin-1. Science 254:430.
67. Denis, M., D. Campbell, and E. O. Gregg. 1991. Interleukin-2 and granulocyte-macrophage colony-stimulating factor stimulate growth of a virulent strain of Escherichia coli. Infect. Immun. 59:1853.
68. Denis, M., and E. O. Gregg. 1991. Recombinant interleukin-6 increases the intracellular and extracellular growth of Mycobacterium avium. Can. J. Microbiol. 37:479.
69. Luo, G., D. W. Niesel, R. A. Shaban, E. A. Grimm, and G. R. Klimpel. 1993. Tumor necrosis factor α binding to bacteria: evidence for a high-affinity receptor and alteration of bacterial virulence properties. Infect. Immun. 61:830.